Catheter Related Bloodstream Infection Market By Drug Class (Cloxacillin, Echinocandin, Ceftazidime, Cefazoline, Daptomycin, and Others), By Route of Administration (Oral and Injectable), By Indication (Bacterial Infections, Fungal Infection, and Viral & Parasitic Infections), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
Report Overview The Catheter Related Bloodstream Infection Market size is expected to be worth around US$ 2.5 billion by 2033 from US$ 1.5 billion in 2023, growing at a CAGR of 5.2% ...